Hemothorax in vascular Ehlers-Danlos syndrome

被引:4
作者
Alvarez, Kevin [1 ]
Lopez, Jordi [2 ]
Angel Hernandez, Jose [3 ]
机构
[1] Complejo Hosp Univ Insular Materno Infantil, Serv Cardiol, Las Palmas Gran Canaria, Las Palmas, Spain
[2] Complejo Hosp Univ Insular Materno Infantil, Serv Neumol, Las Palmas Gran Canaria, Las Palmas, Spain
[3] Complejo Hosp Univ Insular Materno Infantil, Serv Reumatol, Las Palmas Gran Canaria, Las Palmas, Spain
来源
REUMATOLOGIA CLINICA | 2019年 / 15卷 / 06期
关键词
Ehlers-Danlos syndrome; EDS IV; Vascular Ehlers-Danlos syndrome;
D O I
10.1016/j.reuma.2017.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Vascular Ehlers-Danlos syndrome (EDS IV) is a rare genetic disorder characterized by an alteration in the COL3A1 gene which encodes type III collagen. It is the most common type of collagen in vessels of medium size and certain organs such as the intestines and the uterus. The alteration of this type of collagen produces aneurisms and ruptures of vessels and organs. A high level of clinical suspicion is required for diagnosis. It is a complex disease whose management requires a multidisciplinary team to treat the different complications that may occur. We report the case of a 50-year-old man diagnosed with EDS IV detected incidentally after hemothorax secondary to a coughing spell. (C) 2017 Elsevier Espana, S.L.U. and Sociedad Espanola de Reumatologia y Colegio Mexicano de Reumatologia. All rights reserved.
引用
收藏
页码:E128 / E129
页数:2
相关论文
共 6 条
[1]   Treatment of Vascular Ehlers-Danlos Syndrome A Systematic Review [J].
Bergqvist, David ;
Bjorck, Martin ;
Wanhainen, Anders .
ANNALS OF SURGERY, 2013, 258 (02) :257-261
[2]   Diagnosis, natural history, and management in vascular Ehlers-Danlos syndrome [J].
Byers, Peter H. ;
Belmont, John ;
Black, James ;
De Backer, Julie ;
Frank, Michael ;
Jeunemaitre, Xavier ;
Johnson, Diana ;
Pepin, Melanie ;
Robert, Leema ;
Sanders, Lynn ;
Wheeldon, Nigel .
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2017, 175 (01) :40-47
[3]  
Byers PH., GeneReviews Internet
[4]   Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial [J].
Ong, Kim-Thanh ;
Perdu, Jerome ;
De Backer, Julie ;
Bozec, Erwan ;
Collignon, Patrick ;
Emmerich, Joseph ;
Fauret, Anne-Laure ;
Fiessinger, Jean-Noel ;
Germain, Dominique P. ;
Georgesco, Gabriella ;
Hulot, Jean-Sebastien ;
De Paepe, Anne ;
Plauchu, Henri ;
Jeunemaitre, Xavier ;
Laurent, Stephane ;
Boutouyrie, Pierre .
LANCET, 2010, 376 (9751) :1476-1484
[5]   Clinical and genetic features of Ehlers-Danlos syndrome type IV, the vascular type. [J].
Pepin, M ;
Schwarze, U ;
Superti-Furga, A ;
Byers, PH .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (10) :673-680
[6]   COL3A1 mutations cause variable clinical phenotypes including acrogeria and vascular rupture [J].
Pope, FM ;
Narcisi, P ;
Nicholls, AC ;
Germaine, D ;
Richards, AJ .
BRITISH JOURNAL OF DERMATOLOGY, 1996, 135 (02) :163-181